But what is he supposed to do? He cannot comment publicly on the FDA's assessments of drug trials. (Of which there are only two for CFS). Blood safety is a temporary issue that would better addressed by having someone from the Blood Working Group - which has been done. I have been to every CFSAC meeting for the past five or six years and he is rarely asked questions and he rarely has much to answer. After watching all that I honestly think its a waste of taxpayer money to have him there. Maybe he fulfills some functions with the committees..I don;t know. Was he asked even one question over the two days of the meeting?